LALEIatlas

LEI record

· Hong Kong SAR China

CHINAAMC FRANKLIN FTSE GLOBAL INNOVATIVE DRUGS ETF

IssuedActive
2138
00
Y5ZKGD6STOL6
30
Issuer (LOU)
Res.
Entity identifier
Check
Legal form
SUB-FUND
Jurisdiction
Hong Kong SAR China
Registered
2 Jul 2026
Next renewal
2 Jul 2027

Reference data

Identity

LEI
213800Y5ZKGD6STOL630
Legal form
SUB-FUND8888
Registration authority
No Registration Authority available
Legal address
C/O CHINA ASSET MANAGEMENT (HONG KONG) LIMITED, 37/F BANK OF CHINA TOWER, 1 GARDEN ROAD, HONG KONG, HK
HQ address
C/O CHINA ASSET MANAGEMENT (HONG KONG) LIMITED, 37/F BANK OF CHINA TOWER, 1 GARDEN ROAD, HONG KONG, HK
Initial registration
2 Jul 2026
Last updated
2 Jul 2026
Managing LOU (issuer)
LONDON STOCK EXCHANGE LEI LIMITED213800WAVVOPS85N2205

Level 2 · who owns whom

Corporate structure

Direct accounting consolidation parent: Non consolidating
Ultimate accounting consolidation parent: Non consolidating

Securities & codes

Securities and identifiers

No securities, bank or market codes mapped to this entity.

The archive · 1 version

Change history

First recorded in this archive on 6 Jul 2026. Future changes to name, status, address, ownership or renewal date will appear here.

What this means

Plain-language summary

The LEI is a 20-character ISO 17442 code identifying this legal entity in financial transactions. Its legal form is “SUB-FUND”. It is registered in Hong Kong SAR China.

Its LEI was first registered in 2026. Its next annual renewal is due 2 Jul 2027.

Issued is the status of the LEI registration; the entity status (Active) describes whether the legal entity itself still exists.

The mesh

Related entities

Source: GLEIF (CC0)Official record ↗More in Hong Kong SAR China